The role of leptin, resistin, and irisin levels as prognostic indicators of lung cancer in Iraqi patients

References

• Thandra KC, Barsouk A, Saginala K, et al. Epidemiology of lung cancer. Contemp Oncol (Pozn). 2021;25(1):45–52. doi: 10.5114/wo.2021.103829
   PubMed Web of Science ®Google Scholar
• Parma B. Identification of the mitochondrial HSPD1 as metabolic vulnerability in non-small cell lung cancer [ dissertation]. Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU); 2023.
   Google Scholar
• Howlader N, Forjaz G, Mooradian MJ, et al. The effect of advances in lung-cancer treatment on population mortality. N Engl J Med. 2020;383(7):640–649. doi: 10.1056/NEJMoa1916623
   PubMed Web of Science ®Google Scholar
• Seijo LM, Peled N, Ajona D, et al. Biomarkers in lung cancer screening: achievements, promises, and challenges. J Thorac Oncol. 2019;14(3):343–357. doi: 10.1016/j.jtho.2018.11.023
   PubMed Web of Science ®Google Scholar
• Ganster DC, Crain TL, Brossoit RM. Physiological measurement in the organizational sciences: a review and recommendations for future use. Annu Rev Organ Psychol Organ Behav. 2018;5(1):267–293. doi: 10.1146/annurev-orgpsych-032117-104613
   Google Scholar
• Ismaeel GL, Abdul-Hussein AH, Qasim HM, et al. Therapeutic targeting of dormant cancer stem cells in solid tumors. Gene Rep. 2023;30:101717. doi: 10.1016/j.genrep.2022.101717
   Web of Science ®Google Scholar
• Saleem HM, Ramaiah P, Gupta J, et al. Nanotechnology-empowered lung cancer therapy: from EMT role in cancer metastasis to application of nanoengineered structures for modulating growth and metastasis. Environ Res. 2023;232:115942. doi: 10.1016/j.envres.2023.115942
   PubMed Web of Science ®Google Scholar
• Zhu C, Ma H, He A, et al. Exercise in cancer prevention and anticancer therapy: efficacy, molecular mechanisms and clinical information. Cancer Lett. 2022;544:215814. doi: 10.1016/j.canlet.2022.215814
   PubMed Web of Science ®Google Scholar
• Bereda G. Application of leptin in enhancing immunity and maintaining obesity. J Clin Stud Rev Rep. 2023;5(1):1–2. doi: 10.47363/JCCSR/2023(5)239
   Google Scholar
• Jiménez-Cortegana C, López-Saavedra A, Sánchez-Jiménez F, et al. Leptin, both bad and good actor in cancer. Biomolecul. 2021;11(6):913. doi: 10.3390/biom11060913
   PubMed Web of Science ®Google Scholar
• Caruso A, Gelsomino L, Panza S, et al. Leptin: a heavyweight player in obesity-related cancers. Biomolecul. 2023;13(7):1084. doi: 10.3390/biom13071084
   PubMed Web of Science ®Google Scholar
• Karatas F, Yalcin B, Sahin S, et al. The significance of serum leptin level in patients with early stage nonsmall cell lung cancer. J Cancer Res Ther. 2017;13(2):204–207. doi: 10.4103/0973-1482.196859
   PubMed Web of Science ®Google Scholar
• Abdalla MMI. Serum resistin and the risk for hepatocellular carcinoma in diabetic patients. World J Gastroenterol. 2023;29(27):4271. doi: 10.3748/wjg.v29.i27.4271
   PubMed Web of Science ®Google Scholar
• Ashour MA, Wadea FM, Hussein NMM, et al. Insulin resistance, resistin hormone and hepatocellular carcinoma interplay: a review article. Egypt J Hosp Med. 2023;90(2):2041–2044. doi: 10.21608/ejhm.2023.285028
   Google Scholar
• Demiray G, Değirmencioğlu S, Uğurlu E, et al. Effects of serum leptin and resistin levels on cancer cachexia in patients with advanced-stage non–small cell lung cancer. Clin Med Insights Oncol. 2017;11:1179554917690144. doi: 10.1177/1179554917690144
   Web of Science ®Google Scholar
• Zhao CC, Chen J, Niu R, et al. Increased resistin suggests poor prognosis and promotes development of lung adenocarcinoma. Oncol Rep. 2018;40(6):3392–3404. doi: 10.3892/or.2018.6736
   PubMed Web of Science ®Google Scholar
• Gong WJ, Liu J-Y, Yin J-Y, et al. Resistin facilitates metastasis of lung adenocarcinoma through the TLR 4/Src/ EGFR / PI 3K/ NF -κB pathway. Cancer Sci. 2018;109(8):2391–2400. doi: 10.1111/cas.13704
   PubMed Web of Science ®Google Scholar
• Göktepe M, Korkmaz C, Zamani A, et al. Evaluation of serum resistin, visfatin and chemerin levels in patients with lung cancer and chronic obstructive pulmonary disease. Turk Thorac J. 2019;21(3):169. doi: 10.5152/TurkThoracJ.2019.19001
   Web of Science ®Google Scholar
• Temur AA, Rashid FA. The relationship between circulating irisin and oxidative stress in gastric and colorectal cancer patients. Asian Pac J Cancer Prev. 2022;23(8):2649. doi: 10.31557/APJCP.2022.23.8.2649
   PubMedGoogle Scholar
• Aslan R, Alp HH, Eryılmaz R, et al. Can the irisin be a biomarker for prostate cancer? A case control study. Asian Pac J Cancer Prev. 2020;21(2):505–509. doi: 10.31557/APJCP.2020.21.2.505
   PubMedGoogle Scholar
• Temur AA, Rashid FA. Irisin and carcinoembryonic antigen (CEA) as potential diagnostic biomarkers in gastric and colorectal cancers. Rep Biochem Mol Biol. 2021;10(3):488–494. doi: 10.52547/rbmb.10.3.488
   PubMed Web of Science ®Google Scholar
• Liu S, Cui F, Ning K, et al. Role of irisin in physiology and pathology. Front Endocrinol. 2022;13:962–968. doi: 10.3389/fendo.2022.962968
   Web of Science ®Google Scholar
• Stapelfeld C, Dammann C, Maser E. Sex-specificity in lung cancer risk. Int J Cancer. 2020;146(9):2376–2382. doi: 10.1002/ijc.32716
   PubMed Web of Science ®Google Scholar
• Mederos N, Friedlaender A, Peters S, et al. Gender-specific aspects of epidemiology, molecular genetics and outcome: lung cancer. ESMO Open. 2020;5:e000796. doi: 10.1136/esmoopen-2020-000796
   PubMed Web of Science ®Google Scholar
• Ardesch FH, Ruiter R, Mulder M, et al. The obesity paradox in lung cancer: associations with body size versus body shape. Front Oncol. 2020;10:591110. doi: 10.3389/fonc.2020.591110
   PubMed Web of Science ®Google Scholar
• Li M, Cao SM, Dimou N, et al. Association of metabolic syndrome with risk of lung cancer: a population-based prospective cohort study. Chest. 2024;165(1):213–223. doi: 10.1016/j.chest.2023.08.003
   PubMed Web of Science ®Google Scholar
• Hecht SS. Lung carcinogenesis by tobacco smoke. Int J Cancer. 2012;131(12):2724–2732. doi: 10.1002/ijc.27816
   PubMed Web of Science ®Google Scholar
• Alemán MR, Santolaria F, Batista N, et al. Leptin role in advanced lung cancer. A mediator of the acute phase response or a marker of the status of nutrition? Cytokine. 2002;19(1):21–26. doi: 10.1006/cyto.2002.1051
   PubMed Web of Science ®Google Scholar
• Blandin Knight S, Crosbie PA, Balata H, et al. Progress and prospects of early detection in lung cancer. Open Biol. 2017;7(9):170070. doi: 10.1098/rsob.170070
   PubMed Web of Science ®Google Scholar
• Vita E, Stefani A, Piro G, et al. Leptin-mediated meta-inflammation may provide survival benefit in patients receiving maintenance immunotherapy for extensive-stage small cell lung cancer (ES-SCLC). Cancer Immunol Immun. 2023;72(11):3803–3812. doi: 10.1007/s00262-023-03533-0
   PubMed Web of Science ®Google Scholar
• Mou W, Xue H, Tong H, et al. Prognostic value of serum leptin in advanced lung adenocarcinoma patients with cisplatin/pemetrexed chemotherapy. Oncol Lett. 2014;7(6):2073–2078. doi: 10.3892/ol.2014.1988
   PubMed Web of Science ®Google Scholar
• Song CH, Liao J, Deng Z-H, et al. Is leptin a predictive factor in patients with lung cancer? Clin Biochem. 2014;47(3):230–232. doi: 10.1016/j.clinbiochem.2013.12.003
   PubMed Web of Science ®Google Scholar
• Tas F, Duranyildiz D, Argon A, et al. Serum levels of leptin and proinflammatory cytokines in advanced-stage non-small cell lung cancer. Med Oncol. 2005;22(4):353–358. doi: 10.1385/MO:22:4:353
   PubMed Web of Science ®Google Scholar
• Tong H, Mou W, Xue H, et al. Prognostic value of serum leptin in advanced lung adenocarcinoma patients with cisplatin/pemetrexed chemotherapy. Oncol Lett. 2014;7(6):2073–2078.
   PubMed Web of Science ®Google Scholar
• Tong X, Ma Y, Zhou Q, et al. Serum and tissue leptin in lung cancer: a meta-analysis. Oncotarget. 2017;8(12):19699. doi: 10.18632/oncotarget.14963
   PubMedGoogle Scholar
• Bocian-Jastrzębska A, Malczewska-Herman A, Kos-Kudła B. Role of leptin and adiponectin in carcinogenesis. Cancers (Basel). 2023;15(17):4250. doi: 10.3390/cancers15174250
   PubMed Web of Science ®Google Scholar
• Greco M, De Santo M, Comandè A, et al. Leptin-activity modulators and their potential pharmaceutical applications. Biomolecules. 2021;11(7):1045. doi: 10.3390/biom11071045
   PubMed Web of Science ®Google Scholar
• Wang J, Zhou F, Li F, et al. Autocrined leptin promotes proliferation of non-small cell lung cancer (NSCLC) via PI3K/AKT and p53 pathways. Ann Transl Med. 2021;9(7):568–568. doi: 10.21037/atm-20-7482
   PubMed Web of Science ®Google Scholar
• Nigro E, Perrotta F, Monaco ML, et al. Implications of the adiponectin system in non-small cell lung cancer patients: A case-control study. Biomolecules. 2020;10(6):926. doi: 10.3390/biom10060926
   PubMed Web of Science ®Google Scholar
• Sacher AG, Paweletz C, Dahlberg SE, et al. Prospective validation of rapid plasma genotyping for the detection of EGFR and KRAS mutations in advanced lung cancer. JAMA Oncol. 2016;2(8):1014–1022. doi: 10.1001/jamaoncol.2016.0173
   PubMed Web of Science ®Google Scholar
• Sudan SK, Deshmukh SK, Poosarla T, et al. Resistin: an inflammatory cytokine with multi-faceted roles in cancer. Biochimica Et Biophysica Acta (BBA) - Rev Cancer. 2020;1874(2):188419. doi: 10.1016/j.bbcan.2020.188419
   PubMed Web of Science ®Google Scholar
• Kuo CH, Chen K-F, Chou S-H, et al. Lung tumor‐associated dendritic cell‐derived resistin promoted cancer progression by increasing Wolf–Hirschhorn syndrome candidate 1/Twist pathway. Carcinogenesis. 2013;34(11):2600–2609. doi: 10.1093/carcin/bgt281
   PubMed Web of Science ®Google Scholar
• Nowinska N, Jablonska J, Pawelczyk P, et al. Expression of Irisin/FNDC5 in cancer cells and stromal fibroblasts of non-small cell lung cancer. Cancers (Basel). 2019;11(10):1538. doi: 10.3390/cancers11101538
   PubMed Web of Science ®Google Scholar
• Tsiani E, Tsakiridis N, Kouvelioti R, et al. Current evidence of the role of the myokine irisin in cancer. Cancers (Basel). 2021;13(11):2628. doi: 10.3390/cancers13112628
   PubMed Web of Science ®Google Scholar
• Shao L, Li H, Chen J, et al. Irisin suppresses the migration, proliferation, and invasion of lung cancer cells via inhibition of epithelial-to-mesenchymal transition. Biochem Biophys Res Commun. 2017;485(3):598–605. doi: 10.1016/j.bbrc.2016.12.084
   PubMed Web of Science ®Google Scholar
• Zhang D, Tan X, Tang N, et al. Review of research on the role of Irisin in tumors. OTT. 2020;Volume 13:4423–4430. doi: 10.2147/OTT.S245178
   Google Scholar
• Pinkowska A, Podhorska-Okołów M, Dzięgiel P, et al. The role of irisin in cancer disease. Cells. 2021;10(6):1479. doi: 10.3390/cells10061479
   PubMed Web of Science ®Google Scholar